Korean J Otolaryngol-Head Neck Surg.
1997 Aug;40(8):1128-1132.
Amplification of Cyclin D1 in Head and Neck Squamous Cell Carcinomas
- Affiliations
-
- 1Department of Otolaryngology, College of Medicine, Hanyang University, Seoul, Korea.
- 2Department of Medical Genetics, College of Medicine, Hanyang University, Seoul, Korea.
- 3Department of Pathology, College of Medicine, Hanyang University, Seoul, Korea.
Abstract
-
BACKGROUND: Amplification of the chromosome 11q13 region has been observed in a variety of human cancers, including head and neck squamous cell carcinoma and carcinomas of breast, esophagus, lung, bladder, and liver. The chromosome 11q13 region has various putative oncogenes, of which cyclin D1 is most consistently amplfied and overexpressed.
OBJECTIVES
To estabilsh the frequency and clinicopathologic correlations of cyclin D1 amplification in head and neck squamous cell carcinomas.
MATERIALS AND METHODS
Fresh tissue samples were obtained from 26 patients with head and neck cancers undergoing surgery or biopsy. Amplification of cyclin D1 was evaluated in 26 head and neck squamous cell carcinomas by Southern blotting. The presence or absence of amplification was correlated with anatomic site, tumor stage, and differentiation pattern.
RESULTS
Five tumors of 26(19%) showed a twofold to 4-fold amplification of cyclin D1 compared with beta-actin control prove. Amplified and nonamplified groups revealed no differences in anatomic primary site, stage, N stage, and pathologic differentiation.
CONCLUSION
We showed a significant incidence of cyclin D1 amplification in head and neck squamous cell carcinomas, but cannot demonstrate an association with clinical presentation and pathologic findings.